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The use of orthogonal acceleration quadrupole time-of-flight (Q-TOF) mass spectrometry to
determine the collisionally activated dissociation (CAD) of a test compound 1-(3-[5-{1,2,4-
triazol-4-yl}-1H-indol-3-yl]propyl)-4-(2-{3-fluorophenyl}ethyl)piperazine is described. At unit-
mass resolution the identity of many ions is ambiguous because of the complexity of the
resulting product ion spectrum. Using the high resolution capabilities of the Q-TOF instru-
ment, exact masses for each fragment were determined. These data were used to infer
molecular formulas for each fragment through software interpretation and, by further
applying chemical intuition, the majority of ions were fully assigned. Additionally, by utilizing
in-source fragmentation at high cone voltage, analyses of second-generation products allowed
derivation of a consistent sequential fragmentation pathway. This study clearly demonstrates
the power of Q-TOF mass spectrometry to elucidate complex product ion spectra. (J Am Soc
Mass Spectrom 2001, 12, 1145–1152) © 2001 American Society for Mass Spectrometry
The structural elucidation of unknowns from deg-radation or metabolism studies at an early stageof the drug discovery process has been revolu-
tionized by the availability of liquid chromatography–
tandem mass spectrometry (LC-MS/MS) using atmo-
spheric pressure ionization techniques [1–3]. This
hyphenated technique provides the means to interface
an eluent stream directly from a liquid chromatograph
into a mass spectrometer, thereby gaining m/z informa-
tion on the protonated molecule directly. Furthermore,
by operating in product ion mode, fragment ions of a
precursor ion may be generated through CAD, result-
ing in a product ion spectrum which contains valuable
information on the connectivity of the molecule. This is
useful in helping to rationalize where on the molecule a
structural modification has occurred.
There are, however, a number of drawbacks with
tandem mass spectrometry for performing structural
work [4]. First, the absolute sensitivity in product ion
mode is poor, limiting the usefulness for obtaining
full-scan data on trace components. This is particularly
true in drug metabolism studies in which structural
information on circulating or excreted drug metabolites
is required. Given the potency of many current drugs,
pharmacologically active concentrations of the parent
drug are typically in the ng/mL range [5]; hence
concentrations of metabolites are likewise limited. The
limitation in sensitivity in a tandem quadrupole instru-
ment arises from the scanning of the quadrupole design
because in order to generate a product ion spectrum,
the first quadrupole is fixed to transmit only the m/z of
the molecule under investigation, whilst the second
quadrupole must scan the required m/z range. Conse-
quently, at any fixed time the quadrupole acts as a mass
filter by allowing transmission of ions of a defined m/z
ratio but excluding all other ions. Thus, the duty cycle
for detection of any particular product ion is very low.
Second, although CAD may often produce very few
product ions, in other cases highly complex spectra are
obtained which are rich in information but may often be
difficult to interpret, particularly if multiple fragmenta-
tion pathways are present. Furthermore, as the resolu-
tion of the quadrupole is only unit mass, two or more
possible product ions may have the same nominal mass
and are thus impossible to distinguish. This leads to
difficulty and ambiguity in the product ion spectrum
interpretation.
In an effort to overcome these limitations, a potential
solution is to replace the tandem quadrupole with an
orthogonal acceleration Q-TOF combination [6, 7]. By
the nature of the TOF analyzer, ions are packeted and
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accelerated into the flight tube with high frequency
resulting in a relatively high duty cycle in which 5–50%
of generated ions are ultimately detected [8]. This
improvement in efficiency results in at least an order of
magnitude improvement in sensitivity compared to
data from a scanning quadrupole. In addition, the
availability of the quadrupole analyzer and collision
cell before the TOF analyzer in the Q-TOF instrument
allows product ions to be generated in the same manner
as described for a tandem quadrupole instrument.
However, unlike a quadrupole analyzer, in a TOF
analyzer mass calibration is stable over a wide mass
range using only two reference ions [9]. This allows
product ions to be assigned a mass accuracy of 5 ppm
allowing, in many cases, unambiguous assignment and
definitive designation of the fragmentation pathway
[10–12].
As part of our program to profile the selective 5HT1D
agonist 1-(3-[5-{1,2,4-triazol-4-yl}-1H-indol-3-yl]pro-
pyl)-4-(2-{3-fluorophenyl}ethyl)piperazine [13–15] (Fig-
ure 1) it was found that this compound may be catego-
rized as a molecule capable of undergoing multiple
fragmentation pathways at a single collision energy.
This results in complex product ion spectra and so this
compound represented an opportunity to explore the
power of Q-TOF mass spectrometry in an attempt to
assign this spectrum. Such spectral interpretations
would typically be conducted as a prelude to perform-
ing more detailed metabolism studies to rationalize, for
example, the position of a hydroxylation or dealkyla-
tion. The results of this study are discussed and provide
a striking example of the capability of Q-TOF mass
spectrometry for use in structural metabolic studies.
Methods
Mass Spectrometry
Mass spectrometric analysis was performed using a
QTOF II mass spectrometer (Micromass, Manchester,
UK) equipped with a Z-spray electrospray source. The
instrument was operated in positive ion mode with a
capillary voltage of 3400 V and a cone voltage of 30 V.
For some analyses the cone voltage was raised to 80 V
in order to induce in-source fragmentation and allow
CAD of first generation product ions in the collision
hexapole. CAD MS/MS experiments were performed
using the hexapole collision cell with argon as the
collision gas. The collision energy was set to 30 eV, at
which maximal fragmentation was observed while still
retaining sufficient precursor ion as a lock mass. The
quadrupole mass filter before to the TOF analyzer was
set with LM and HM resolution of 15.0 (arbitrary units)
which is equivalent to a 1.0 Da mass window for
transmission of precursor ions. Analysis of the resultant
product ions were made using the TOF analyzer incor-
porating a reflector, micro-channel plate detector, and
time-to-digital converter. Signal acquisition and data
processing were performed using MassLynx software
Version 3.4 (Micromass).
The instrument resolution was tuned to be 4000 as
measured at full width at half maximum (FWHM) for
the singly charged molecular ion. Calibration was per-
formed using a mixture of NaI and RbI from m/z
100–900 in positive ion mode with the mass accuracy
being 5 ppm for this mass range, determined by
re-infusing NaI and RbI and measuring the mass devi-
ation of observed versus known masses using the new
calibration.
The analyte was infused into the mass spectrometer
using a Harvard Apparatus syringe pump (Holliston,
MA) at a flow rate of 0.1–1 mL/h. The test compound
was dissolved at a concentration of 1 g/mL in a 1:1
mixture of acetonitrile and 25 mM ammonium formate,
adjusted to pH 3.0 with formic acid.
Results and Discussion
The product ion spectrum at a collision energy of 30 eV
for the test compound obtained using orthogonal accel-
eration TOF MS is shown (Figure 2). The spectrum
shows product ions of m/z 433 obtained by setting the
quadrupole to transmit only this mass, with the TOF
analyzer detecting the resulting fragment ions follow-
ing CAD. The inherent stability of the TOF analyzer
allows mass accuracy of better than 50 ppm using just
an external two-point calibration, but mass accuracy
may be improved further by including an internal
calibration point or lock mass. In this instance, since the
molecule is a known entity, one may use the precursor
ion (m/z 433.2516) which will be present in the same
scans as the product ions to be measured.
As part of the software suite provided with the
instrument, one can interrogate such a spectrum and
generate an elemental composition report for each of
the fragments. The results for products of m/z 433 are
tabulated in Table 1 along with the molecular formulas
predicted within 5 mDa of the exact mass. In the case
where more than one formula is proposed, the formula
shown is the one matching the proposed structure.
Rationalization of prefering one structure over another
is discussed further below. This threshold of 5 mDa is
chosen as the mass accuracy of the nominal mass
calibration; hence it would be expected that the accurate
mass of a fragment should lie within a 5 mDa window
of the exact mass.
Clearly, even with a mass accuracy of 0.1 mDa, if one
were to consider a combination of all possible elements
Figure 1. Structure of test compound 1-(3-[5-{1,2,4-triazol-4-yl}-
1H-indol-3-yl]propyl)-4-(2-{3-fluorophenyl}ethyl)piperazine.
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for a molecule of mass 400 Da, this could potentially
generate many combinations for each found fragment.
However, in the case of fragmentation of a precursor
ion of known molecular composition rather than the
identification of a complete unknown, since the starting
molecular formula is known, the composition of the
fragment ions is limited because it is impossible for
them to contain more of each element than is present in
the precursor. Therefore, one may limit the search to
only those elements in the precursor molecule and to
the relative amounts of each of them. Furthermore, even
if two or more formulas are predicted from the ob-
served mass, by comparing the deviation between cal-
culated and observed mass for the possibilities, one of
the outcomes may be more probable. However, should
this not prove sufficient, the knowledge of the precur-
sor molecular structure will most likely indicate which
fragments are possible and which are not on chemical
grounds. For example, if certain heteroatoms are prox-
imally located in the molecule, it is more likely that
these will remain together in subsequent fragments
than if they are distal.
In considering the fragmentation pathways resulting
from low energy CAD, it is often instructive to addi-
tionally consider the neutral fragment that is lost as a
result of the cleavage as this may give a clue to the
resultant fragment ion. The initial fragment (F1) corre-
sponds to a neutral loss of hydrogen cyanide (HCN)
and this may be rationalized most probably as the
cleavage and subsequent ring contraction of the N-
linked 1,3,4 triazole. Clearly this may rearrange further
but may be formally represented as a three-membered
diazole ring attached to the indole (Figure 3a). The
second fragment (F2) is less easy to formally rationalize,
representing a loss of CH2N2 from the precursor mole-
cule. This again suggests a cleavage of the triazole
moiety, but in this case to deliver a reasonable structure
for F2, one may assume that the triazole rearranges to
incorporate the remaining triazole C and N atoms into
the indole ring forming a C9H9 aromatic cation species.
Alternative structures in which the C and N atoms
either cyclize onto the indole or switch to form a
cyano-substituted indole may also be concluded as
Figure 2. Product ion spectrum of 1-(3-[5-{1,2,4-triazol-4-yl}-1H-indol-3-yl]propyl)-4-(2-{3-
fluorophenyl}ethyl)piperazine following CAD of m/z 433.
Figure 3. Proposed structure of (a) fragment F1 resulting from
loss of HCN from the parent triazole and (b) fragment F2 resulting
from loss of CH2N2 from the parent triazole.
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being consistent with the molecular formula. For the
sake of ease of representation the former format will be
adopted although it is appreciated that in reality this
structure may not exist (Figure 3b).
The importance of the discussion surrounding F1
and F2 becomes apparent when considering many of
the low mass fragments, as examination of these reveal
some differences of both 27 and 42 Da suggesting that
the precursor ion with the triazole intact undergoes a
particular fragmentation pathway and that both of the
M-27 and M-42 species are also able to fragment in
analogous ways. To test this hypothesis, two experi-
ments were conducted in which the cone voltage was
increased from 30 V to 80 V in order to induce in-source
fragmentation to generate both F1 and F2. These were
then selected sequentially by setting the quadrupole to
transmit only these ions and TOF product ion spectra
generated for each. The product ion spectra for F1
(Figure 4) and F2 (Figure 5) are shown. The fragment
ions for these spectra are assigned as F1–F26, as for
Figure 2, where the m/z ratios are observed to correlate
within 5 mDa of those observed for products of m/z 433.
It may be deduced that both F1 and F2 are ions formed
directly from the precursor ion, as F1 does not fragment
to give F2. Furthermore, while there are unique F1 and
F2 fragments, many ions are common to both suggest-
ing that these are not concerned with the indole portion
of the molecule but with the phenethylpiperazine moi-
ety. Lastly, two fragments (F11 and F16) are uniquely
generated from the precursor ion but not F1 or F2,
suggesting that these contain triazole–indole. If CAD is
performed on F11, not only is F16 generated as a
fragment ion but also a number of ions formed by F1
(Figure 6).
In order to rationalize this complex data, a Venn
diagram analysis of the product ions that are either
uniquely formed by F1, F2, or F11 or generated by more
than one fragment is given (Figure 7). This also shows
the proposed structures which are consistent with the
predicted formulas and the fragmentation scheme. On
the left of the diagram, the fragments formed from the
initial neutral loss of HCN from the triazole are shown
which may be generated from F1 or F11. Likewise, on
the right hand side of the diagram, an analogous series
of fragments are observed resulting from the neutral
loss of CH2N2 from the triazole. Common fragments
which may be formed by either the precursor, F1 or F2
are shown in the center and all are the result of cleavage
of the piperazine side chain which would be entirely
plausible chemically.
The use of such a categorization according to the
precursor ion is helpful in rationalizing the structure
either per se or where more than one formula may be
generated for a given mass. For example, since it is
known that F1 does not generate F2, any F2-type
structures must have been generated from the F2 pre-
Table 1. Exact masses and inferred molecular formulas for fragments of m/z 433
Fragment
Measured mass
(Da) Predicted formula
Calculated mass
(Da)
Error
(mDa)
Error
(ppm)
433.2516 C25 H30 N6 F 433.2516 0.0 0.0
F1 406.2398 C24 H29 N5 F 406.2407 0.9 2.2
F2 391.2285 C24 H28 N4 F 391.2298 1.3 3.3
F3 284.1873 C16 H22 N5 284.1875 0.2 0.8
F4 283.1793 C16 H21 N5 283.1797 0.4 1.4
F5* 281.1703 C20 H22 F 281.1706 0.3 0.9
F6 269.1763 C16 H21 N4 269.1766 0.3 1.2
F7* 268.1618 C19 H21 F 268.1627 0.9 3.5
F8 241.1464 C14 H17 N4 241.1453 1.1 4.5
F9 235.1611 C14 H20 N2 F 235.1611 0.0 0.2
F10 226.1334 C14 H16 N3 226.1344 1.0 4.5
F11 225.1142 C13 H13 N4 225.1140 0.2 0.8
F12 221.1449 C13 H18 N2 F 221.1454 0.5 2.3
F13 209.1456 C12 H18 N2 F 209.1454 0.2 0.9
F14 206.1221 C12 H15 N2 F 206.1219 0.2 0.8
F15 198.1032 C12 H12 N3 198.1031 0.1 0.4
F16 197.0820 C11 H9 N4 197.0827 0.7 3.7
F17 183.0908 C12 H11 N2 183.0922 1.4 7.8
F18 178.1025 C11 H13 N F 178.1032 0.7 3.9
F19 170.0705 C10 H8 N3 170.0718 1.3 7.8
F20 166.1027 C10 H13 N F 166.1032 0.5 3.0
F21* 157.0861 C6 H10 N4 F 157.0889 2.8 18.1
F22* 155.0595 C5 H6 N5 F 155.0607 1.2 7.9
F23 127.1241 C7 H15 N2 127.1235 0.6 4.5
F24 123.0613 C8 H8 F 123.0610 0.3 2.4
F25 99.0919 C5 H11 N2 99.0922 0.3 3.3
F26 97.0765 C5 H9 N2 97.0766 0.1 0.8
* Asterisk (*) indicates those ions for which no logical assignment has been made; in these cases the predicted molecular formulas shown are those
with the minimum error from the exact mass.
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cursor. Therefore, if one were to propose a structure to
fit a formula for a fragment generated from F2, a
structure with an intact triazole or with just the loss of
HCN from the triazole is an impossibility. Similarly,
given two equally likely structures based on the for-
mula, the more likely structure will be the one most
consistent with its immediate precursor.
In considering the fragmentation pathway, it is
tempting to suggest a sequence F1-F3-F8-F15-F19 as a
series of losses of neutral fragments, which would
appear logical given evidence such as F11 generating
F16 through loss of ethylene. However, since intensities
for these ions are low it was not possible to generate
sequential fragmentation data to substantiate this. Frag-
ments F5, F7, F21, and F22 have been assigned areas on
the Venn diagram according to their precursor ion but
structural elucidation for these fragments has still
proved challenging, as discussed further below.
Figure 4. Second-generation product ion spectrum of m/z 406 following in-source fragmentation of
m/z 433.
Figure 5. Second-generation product ion spectrum of m/z 391 following in-source fragmentation of
m/z 433.
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An additional powerful element in generating exact
mass data is the ability to distinguish otherwise ambig-
uous isobaric species. However, with complex mole-
cules it is often possible that more than one molecular
formula may fit the found mass within the limits of
accuracy and precision. In many cases, a simple com-
parison of the calculated versus observed mass will
predict one to be more likely than the other based on the
error between them. In this case, if one were to consider
the example of F15, both C12H12N3 and C7H11N6F fit the
found mass to within 5 mDa. To distinguish the correct
formula it is necessary to go further than this and
invoke some chemical knowledge regarding the con-
nectivity of the molecule. The formula C12H12N3 pre-
dicts that half of the starting nitrogen atoms are present
in the same fragment whereas C7H11N6F predicts that
all of six nitrogen atoms and the fluorine atom are
located in the same fragment. Since the fluorine atom is
located on the terminal phenyl ring, yet the nitrogen
atoms are dispersed throughout the structure, the prob-
ability of a rearrangement that places all nitrogen atoms
and a fluorine in the same fragment is very low indeed,
particularly as a plausible structure may be invoked for
C12H12N3. Whilst such a rationalization of the data is
currently beyond the capabilities of existing software
algorithms, it must clearly be a goal of future interpre-
tational software routines to add this sort of capability.
As suggested, it has not been possible to rationalize
all fragments using a 5 mDa cut-off to predict molecular
formula. In these experiments, the instrument was
deliberately tuned to a resolving power of 4000
(FWHM) rather than the maximum achievable resolu-
tion of 10,000 to allow the measurement of low abun-
dance ions which at higher resolution were not detected
because of the trade-off between resolving power and
sensitivity. At lower signal intensities it could be rea-
soned that the ion statistics deteriorate and may there-
fore influence the mass accuracy, but this is difficult to
reconcile as F3 is consistently predicted with 5 mDa yet
the formula predicted for F5 appear intractable al-
though the ion intensities are comparable. One can
make predictions for the undetermined ions by relaxing
the 5 mDa threshold, but these are inconsistent with
their precursor ions (i.e., their position on the Venn
diagram) and so implausible. It is possible that formu-
las that appear chemically nonsensical, when consider-
ing fragmentation in terms of linear cleavage processes,
may in fact be true because of poorly understood
rearrangement processes but this would require further
investigation.
A further possible complexity is illustrated by the
unknown fragment F5. As a fragment from the m/z 433,
this generates an ion m/z 281.1703 and only one molec-
ular composition (5 mDa) is predicted. However, as a
fragment of F1 m/z 281.1621 is observed, and from F2
m/z 281.1739 is seen. It is possible therefore that these
are different molecular entities as there is an 11.8 mDa
difference in the mass between the F5 ions generated
from F1 and F2. This is highlighted by considering an
ion from the same spectra such as F12, also formed by
parent, F1 and F2 in which the the m/z ratios are
221.1449, 221.1419, and 221.1390 respectively, a spread
of only3 mDa from the mean and 6 mDa from highest
to lowest value. This may reveal limitations in the
current prediction software or in the mass-accuracy of
the instrument. More work will be required to fully
elucidate these current apparent shortcomings.
In summary, given the mass accuracy of the Q-TOF
Figure 6. Second-generation product ion spectrum of m/z 225 following in-source fragmentation of
m/z 433.
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mass spectrometer, even given a relatively complex
CAD mass spectrum such as that seen for the test
compound, by restricting the search for potential for-
mulas to only those elements found in the precursor in
many cases unambiguous assignments of the molecular
formula for each of the mass fragments may be made.
Even in the case where two possible molecular formulas
were found that could not be distinguished on the basis
of their deviation from the theoretical mass, knowledge
of the precursor structure was enough to select the most
appropriate formula. Although it could be argued that
many assignments presented here could be made based
on the nominal mass obtained on a tandem quadrupole
instrument, assignments made using exact mass ensure
substantially higher speed and confidence. The lack of
ambiguity with such data suggests that TOF and par-
ticularly Q-TOF should become an increasingly essen-
tial tool for the analyst involved in any form of struc-
tural assignment, but particularly at trace levels.
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